Pre-treatment patient variables as predictors of drop-out and treatment outcome in cognitive behavioural therapy for social phobia: A systematic review

Nordic Journal of Psychiatry

Volumn 64, Issue 2, 2010, Pages 94-105

  Eskildsen, Anita ^a,b   Hougaard, Esben ^a   Rosenberg, Nicole K ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cognitive behavioural therapy; Drop out; Patient variables; Predictive variables; Prognostic variables; Social phobia

Indexed keywords

ANGER; ANXIETY DISORDER; ARTICLE; AVOIDANT PERSONALITY DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; GROUP THERAPY; HUMAN; MALADJUSTMENT; SOCIAL PHOBIA; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

COGNITIVE THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; PATIENT DROPOUTS; PERSONALITY DISORDERS; PERSONALITY INVENTORY; PHOBIC DISORDERS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 77951098246     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.3109/08039480903426929     Document Type: Article

References (61)

1. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders (DSM-IV), 4th edition. Washington, DC: APA; 1995.
2. Furmark T. Social phobia: Overview of community surveys. Acta Psychiatr Scand 2002;105:84-93.
3. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al. Prevalence of mental disorders in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004;109 Suppl 420:21-27
4. Coles ME, Horng B. Social anxiety disorder. In: Andrasik F, editor. Comprehensive handbook of personality and psychopathology: Vol.2: Adult psychopathology. Hoboken, NJ: John Wiley & Sons Inc; 2006. p. 138-153
5. Fedoroff IC, Taylor S. Psychological and pharmacological treatments of social phobia: A meta-analysis. J Clin Psychopharmacol 2001;21:311-324
6. Kessler RC. The impairments caused by social phobia in the general population: Implications for intervention. Acta Psychiatr Scand 2003;108 Suppl 417:19.
7. Rowa K, Antony MM. Psychological treatments for social phobia. Can J Psychiatry 2005;50:308-316
8. Hofmann SG, Bögels SM. Recent advances in the treatment of social phobia: Introduction to the special issue. J Cogn Psychother. Special Issue: Recent advances in the treatment of social phobia 2006;20:3-5.
9. Norton PJ, Price EC. A meta-analytic review of adult cognitive- behavioral treatment outcome across the anxiety disorders. J Nerv Ment Dis 2007;195:521-531
10. Rodebaugh TL, Holaway RM, Heimberg RG. The treatment of social anxiety disorder. Clin Psychol Rev 2004;24:883-908.
11. Cohen J. Statistical power analysis for the behavioral sciences, 2nd edition. Mahwah, NJ: Lawrence Erlbaum Associates; 1988.
12. Hofmann SG, Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebocontrolled trials. J Clin Psychiatry 2008;69:621-632
13. Gould RA, Buckminster S, Pollack MH, Otto MW, Yap L. Cognitive- behavioral and pharmacological treatment for social phobia: A metaanalysis. Clin Psychol: Sci Pract 1997;4:291-306.
14. Ruipérez MA, García-Palacios A, Botella C. Clinical features and treatment response in social phobia: Axis II comorbidity and social phobia subtypes. Psicothema 2002;14:426-433
15. Scholing A, Emmelkamp PMG. Prediction of treatment outcome in social phobia: A cross-validation. Behav Res Ther 1999;37:659-670.
16. Steketee G, Chambless DL. Methodological issues in prediction of treatment outcome. Clin Psychol Rev 1992;12:387-400.
17. American Psychological Association. Evidence-based practice in psychology: APA Task Force on Evidence-based Practice. Am Psychol 2006;61:271-285
18. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-1182
19. Zaider TI, Heimberg RG. Non-pharmacologic treatments for social anxiety disorder. Acta Psychiatr Scand Suppl 2003;108:72-84.
20. Lincoln TM, Rief W, Hahlweg K, Frank M, Von Witzleben I, Schroeder B, et al. Who comes, who stays, who profits? Predicting refusal, dropout, success, and relapse in a short intervention for social phobia. Psychother Res 2005;15:210-225
21. Heimberg RG, Juster HR, Hope DA, Mattia JI. Cognitive-behavioral group treatment: Description, case presentation, and empirical support. Washington, DC: American Psychiatric Association; 1995.
22. Ledley DR, Huppert JD, Foa EB, Davidson JR, Keefe FJ, Potts NL. Impact of depressive symptoms on the treatment of generalized social anxiety disorder. Depress Anxiety 2005;22:161-167
23. Huppert JD, Strunk DR, Ledley DR, Davidson JR, Foa EB. Generalized social anxiety disorder and avoidant personality disorder: Structural analysis and treatment outcome. Depress Anxiety 2008;25:441-448
24. Oosterbaan DB, van Balkom AJLM, Spinhoven P, de Meij TGJ, van Dyck R. The infl uence on treatment gain of comorbid avoidant personality disorder in patients with social phobia. J Nerv Ment Dis 2002;190:41-43
25. Erwin BA, Heimberg RG, Schneier FR, Liebowitz MR. Anger experience and expression in social anxiety disorder: Pretreatment profile and predictors of attrition and response to cognitive- behavioral treatment. Behav Ther 2003;34:331-350
26. Hofmann SG, Suvak M. Treatment attrition during group therapy for social phobia. J Anxiety Disord 2006;20:961-972 (Pubitemid 44247531)
27. Van Velzen CJM, Emmelkamp PMG, Scholing A. The impact of personality disorders on behavioral treatment outcome for social phobia. Behav Res Ther 1997;35:889-900.
28. Rosser S, Issakidis C, Peters L. Perfectionism and social phobia: Relationship between the constructs and impact on cognitive behavior therapy. Cogn Ther Res 2003;27:143-151
29. McEvoy PM. Effectiveness of cognitive behavioural group therapy for social phobia in a community clinic: A benchmarking study. Behav Res Ther 2007;45:3030-3040
30. Erwin BA, Heimberg RG, Juster H, Mindlin M. Comorbid anxiety and mood disorders among persons with social anxiety disorder. Behav Res Ther 2002;40:19-35.
31. Joormann J, Kosfelder J, Schulte D. The impact of comorbidity of depression on the course of anxiety treatments. Cogn Ther Res 2005;29:569-591
32. Chambless DL, Tran GQ, Glass CR. Predictors of response to cognitive- behavioral group therapy for social phobia. J Anxiety Disord 1997;11:221-240
33. Feske U, Perry KJ, Chambless DL, Renneberg B, Goldstein AJ. Avoidant personality disorder as a predictor for treatment outcome among generalized social phobics. J Personal Disord 1996;10:174-184
34. Cox BJ, Walker JR, Enns MW, Karpinski DC. Self-criticism in generalized social phobia and response to cognitive-behavioral treatment. Behav Ther 2002;33:479-491
35. Safren SA, Heimberg RG, Juster HR. Clients' expectancies and their relationship to pretreatment symptomatology and outcome of cognitive-behavioral group treatment for social phobia. J Consult Clin Psychol 1997;65:694-698
36. Brown EJ, Heimberg RG, Juster HR. Social phobia subtype and avoidant personality disorder: Effect on severity of social phobia, impairment, and outcome of cognitive behavioral treatment. Behav Ther 1995;26:467-486
37. Huppert JD, Strunk DR, Ledley DR, Davidson JR, Foa EB. Generalized social anxiety disorder and avoidant personality disorder: Structural analysis and treatment outcome. Depress Anxiety 2007; Jul 6.
38. Stangier U, Trenk-Hinterberger I, Erfert N, Heidenreich T. Soziale Phobie und Vermeidend-Selbstunsichere Persönlichkeitsstörung: Komorbidität und Behandlungsprognose in kognitiv-behavioraler Therapie [Social phobia and avoidant personality disorder: Comorbidity and treatment prognosis in cognitive-behavioral therapy]. PTT: Persönlichkeitsstö rungen Theorie und Therapie 2001;5:248-262
39. Bogels SM. Task concentration training versus applied relaxation, in combination with cognitive therapy, for social phobia patients with fear of blushing, trembling, and sweating. Behav Res Ther 2006;44:1199-1210
40. Ashbaugh A, Antony MM, Liss A, Summerfeldt LJ, McCabe RE, Swinson RP. Changes in perfectionism following cognitive-behavioral treatment for social phobia. Depress Anxiety 2007;24:169-177
41. Mennin DS, Heimberg RG, Jack MS. Comorbid generalized anxiety disorder in primary social phobia: Symptom severity, functional impairment, and treatment response. J Anxiety Disord 2000;14:325-343
42. McEvoy PM, Shand F. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders. J Anxiety Disord 2008;22:1087-1098
43. Derogatis LR. SCL-90-R: Administration, scoring, and procedures manual I. Baltimore, MD: Clinical Psychometric Research; 1977.
44. Mersch PP, Emmelkamp PM, Bögels SM, Van der Sleen J. Social phobia: Individual response patterns and the effects of behavioral and cognitive interventions. Behav Res Ther 1989;27:421-434
45. Herbert JD, Gaudiano BA, Rheingold AA, Myers VH, Dalrymple K, Nolan EM. Social skills training augments the effectiveness of cognitive behavioral group therapy for social anxiety disorder. Behav Ther 2005;36:125.
46. Rosser S, Erskine A, Crino R. Pre-existing antidepressants and the outcome of group cognitive behaviour therapy for social phobia. Aust NZ J Psychiatry 2004;38:233-239
47. Spielberger DD. Manual for the State-Trait Anger Expression Inventory. Odessa, FL: Psychological Assessment Resources; 1988.
48. Coles ME, Heimberg RG. Patterns of anxious arousal during exposure to feared situations in individuals with social phobia. Behav Res Ther 2000;38:405-424
49. Leung AW, Heimberg RG. Homework compliance, perceptions of control, and outcome of cognitive-behavioral treatment of social phobia. Behav Res Ther 1996;34:423-432
50. Corning AF, Malofeeva EV. The application of survival analysis to the study of psychotherapy termination. J Counsel Psychol 2004;51:354-367
51. Taylor S. Understanding and treating panic disorder: Cognitive behavioural approaches. New York: Wiley & Sons; 2000.
52. National Institute of Clinical Excellence. Post-traumatic stress disorder: The management of PTSD in adults and children in primary and secondary care. National Clinical Practice Guideline Number London: National Institute for Clinical Excellence; 2005.
53. Suls D, Bunde D. Anger, anxiety, and depression as risk factors for cardiovascular disease: The problems and implications of overlapping affective disposition. Psychol Bull 2005;131:260-300.
54. CONSORT Group. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001;134:663-694
55. Boutron I, Moher F, Altman D, Schulz KF, Ravaud P. Extending the Consort statement to randomized trials of nonpharmacological treatment: Explanation and elaboration. Ann Intern Med 2008;148:295-309. (Pubitemid 351665487)
56. Hofmann SG, Heinrichs N, Moscovitch DA. The nature and expression of social phobia: Toward a new classification. Clin Psychol Rev 2004;24:769-797
57. Dance KA, Neufield RWJ. Aptitude-treatment interaction research in the clinical setting: A review of attempts to dispel the "patient uniformity" myth. Psychol Bull 1988;104:192-213.
58. Maruyama GM. Basics of structural equation modeling. Thousand Oaks, CA: Sage Publications; 1998.
59. Edwards DJA, Dattilio FM, Bromley DB. Developing evidencebased practice: The role of case-based research. Prof Psychol: Res Pract 2004;35:589-597
60. Fishman DB. Editor's introduction to PCSP-From single case to database: A new method for enhancing psychotherapy practice. Pragm Case Stud Psychother 2005;1:1-50.
61. Hofmann SG. Cognitive mediation of treatment change in social phobia. J Consult Clin Psychol 2004;72:392-399